Eveline Van Keymeulen, Senior Associate, Allen & Overy

1. Please can you tell me a little bit more about the talk that you will give at the conference?

Rather than a lecture-style ‘talk’ about the key changes introduced by the new Clinical Trial Regulation, my co-speakers and I intend this session to be an interactive discussion on the improvements and pitfalls of the new clinical trials regime.

The discussion will cover the revised streamlined procedures and welcome reducing of regulatory red tape, but – undoubtedly – a large part of the session will focus on the legal and practical implications of increased transparency of clinical trial data for pharmaceutical companies as well. 

2. Who will be most interested in the subject matter of your presentation?

Everyone with a ‘healthy’ interest in one of the hottest life sciences topics of this very moment. 

3. What do you expect delegates to “take away” with them from your talk?

A handy ‘pocket guide’ to the new clinical trials regime and some ‘best practices’ for ensuring a smooth transition, though above all: good memories of an inspiring session, and some food for thought to discuss during the coffee break. 

4. Which presentations are you most looking forward to attending?

I am very much looking forward to hearing more industry perspectives on biosimilar strategies, a hot topic close to my heart, and to the post-conference workshop on off-label use, given the turbulent regulatory developments in this area (most notably in France and Italy).

5. What is the most challenging part of your job?

Getting out of bed in the mornings.

6. How long have you been working at your current company [/association/organisation]?

I have been a life sciences regulatory lawyer since 2008, and I joined Allen & Overy LLP approximately 1.5 years ago to strengthen the development of their regulatory life sciences practice, the hub of which is – not unpleasantly – based in Paris.

 7. Why did you first get involved in this field?

As a child, I had a hard time making up my mind between becoming a physician or a lawyer, and by practicing life sciences law I have managed to combine the best of both worlds.